| MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses … S Jarius, K Ruprecht, I Kleiter, N Borisow, N Asgari, K Pitarokoili, F Pache, ... Journal of neuroinflammation 13, 1-45, 2016 | 923 | 2016 |
| Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients S Jarius, K Ruprecht, B Wildemann, T Kuempfel, M Ringelstein, C Geis, ... Journal of neuroinflammation 9, 1-17, 2012 | 881 | 2012 |
| MOG encephalomyelitis: international recommendations on diagnosis and antibody testing S Jarius, F Paul, O Aktas, N Asgari, RC Dale, J De Seze, D Franciotta, ... Journal of neuroinflammation 15, 1-10, 2018 | 790 | 2018 |
| Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress U Seifert, LP Bialy, F Ebstein, D Bech-Otschir, A Voigt, F Schröter, ... Cell 142 (4), 613-624, 2010 | 677 | 2010 |
| MRI characteristics of neuromyelitis optica spectrum disorder: an international update HJ Kim, F Paul, MA Lana-Peixoto, S Tenembaum, N Asgari, J Palace, ... Neurology 84 (11), 1165-1173, 2015 | 662 | 2015 |
| Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS) C Trebst, S Jarius, A Berthele, F Paul, S Schippling, B Wildemann, ... Journal of neurology 261, 1-16, 2014 | 658 | 2014 |
| Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial BAC Cree, JL Bennett, HJ Kim, BG Weinshenker, SJ Pittock, ... The Lancet 394 (10206), 1352-1363, 2019 | 657 | 2019 |
| Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis A Petzold, LJ Balcer, PA Calabresi, F Costello, TC Frohman, EM Frohman, ... The Lancet Neurology 16 (10), 797-812, 2017 | 568 | 2017 |
| Sirt1 contributes critically to the redox-dependent fate of neural progenitors T Prozorovski, U Schulze-Topphoff, R Glumm, J Baumgart, F Schröter, ... Nature cell biology 10 (4), 385-394, 2008 | 538 | 2008 |
| The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases F Zipp, O Aktas Trends in neurosciences 29 (9), 518-527, 2006 | 446 | 2006 |
| Neuromyelitis optica: evaluation of 871 attacks and 1,153 treatment courses I Kleiter, A Gahlen, N Borisow, K Fischer, KD Wernecke, B Wegner, ... Annals of neurology 79 (2), 206-216, 2016 | 439 | 2016 |
| Myelin-oligodendrocyte glycoprotein antibody-associated disease R Marignier, Y Hacohen, A Cobo-Calvo, AK Pröbstel, O Aktas, ... The Lancet Neurology 20 (9), 762-772, 2021 | 434 | 2021 |
| MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: frequency, syndrome specificity, influence of disease activity, long-term course, association … S Jarius, K Ruprecht, I Kleiter, N Borisow, N Asgari, K Pitarokoili, F Pache, ... Journal of neuroinflammation 13, 1-16, 2016 | 433 | 2016 |
| Characteristics of Susac syndrome: a review of all reported cases J Dörr, S Krautwald, B Wildemann, S Jarius, M Ringelstein, T Duning, ... Nature Reviews Neurology 9 (6), 307-316, 2013 | 414 | 2013 |
| Green tea epigallocatechin-3-gallate mediates T cellular NF-κB inhibition and exerts neuroprotection in autoimmune encephalomyelitis O Aktas, T Prozorovski, A Smorodchenko, NE Savaskan, R Lauster, ... The Journal of Immunology 173 (9), 5794-5800, 2004 | 410 | 2004 |
| Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures S Jarius, F Paul, D Franciotta, K Ruprecht, M Ringelstein, R Bergamaschi, ... Journal of the neurological sciences 306 (1-2), 82-90, 2011 | 402 | 2011 |
| Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study EH Martinez-Lapiscina, S Arnow, JA Wilson, S Saidha, JL Preiningerova, ... The Lancet Neurology 15 (6), 574-584, 2016 | 393 | 2016 |
| Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin O Aktas, S Waiczies, A Smorodchenko, J Dörr, B Seeger, T Prozorovski, ... The Journal of experimental medicine 197 (6), 725-733, 2003 | 379 | 2003 |
| Indolamine 2, 3‐dioxygenase is expressed in the CNS and down‐regulates autoimmune inflammation E Kwidzinski, J Bunse, O Aktas, D Richter, L Mutlu, F Zipp, R Nitsch, ... The FASEB Journal 19 (10), 1347-1349, 2005 | 349 | 2005 |
| Failure of natalizumab to prevent relapses in neuromyelitis optica I Kleiter, K Hellwig, A Berthele, T Kümpfel, RA Linker, HP Hartung, F Paul, ... Archives of neurology 69 (2), 239-245, 2012 | 344 | 2012 |
Friedemann PaulProfessor für klinische Neuroimmunologie, Charité Universitätsmedizin BerlinOverená e-mailová adresa na: charite.de
